Pharmacoeconomic review report.: (Novartis pharmaceuticals Canada Inc.) : indication : for prevention of migraine in adults who have had at least four migraine days monthly.Version: Final (with redactions)



Bok Engelsk
Annen tittel

Bibliotek som har denne